TEKELI TAŞKÖMÜR, A.; ERTEN, Özlem; DILBAZ, B. Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 µg ethinylestradiol/3 mg drospirenone (24/4) versus 30 µg ethinylestradiol/3 mg drospirenone (21/7). Journal of Surgery and Medicine, [S. l.], v. 5, n. 11, p. 1099–1103, 2021. DOI: 10.28982/josam.1002126. Disponível em: https://jsurgmed.com/article/view/1002126. Acesso em: 28 nov. 2022.